The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Oral pre-exposure prophylaxis (PrEP) to prevent HIV: a systematic review and meta-analysis of clinical effectiveness, safety, adherence and risk compensation in all populations
Open accessAbstract
Objective: To conduct a systematic review and meta-analysis of randomised controlled trials (RCTs) of the effectiveness and safety of oral pre-exposure prophylaxis (PrEP) to prevent HIV. Methods: Databases (PubMed, Embase and the Cochrane Register of Controlled Trials) were searched up to 5 July 2020. Search terms for ‘HIV’ were combined with terms for ‘PrEP’ or ‘tenofovir/emtricitabine’. RCTs were included that compared oral tenofovir-containing PrEP to placebo, no treatment or alternative medication/dosing schedule. The primary outcome was the rate ratio (RR) of HIV infection using a modified intention-to-treat analysis. Secondary outcomes included safety, adherence and risk compensation. All analyses were stratified a priori by population: men who have sex with men (MSM), serodiscordant couples, heterosexuals and people who inject drugs (PWIDs). The quality of individual studies was assessed using the Cochrane risk-of-bias tool, and the certainty of evidence was assessed using GRADE. Results: Of 2803 unique records, 15 RCTs met our inclusion criteria. Over 25 000 participants were included, encompassing 38 289 person-years of follow-up data. PrEP was found to be effective in MSM (RR 0.25, 95% CI 0.1 to 0.61; absolute rate difference (RD) −0.03, 95% CI −0.01 to −0.05), serodiscordant couples (RR 0.25, 95% CI 0.14 to 0.46; RD −0.01, 95% CI −0.01 to −0.02) and PWID (RR 0.51, 95% CI 0.29 to 0.92; RD −0.00, 95% CI −0.00 to −0.01), but not in heterosexuals (RR 0.77, 95% CI 0.46 to 1.29). Efficacy was strongly associated with adherence (p<0.01). PrEP was found to be safe, but unrecognised HIV at enrolment increased the risk of viral drug resistance mutations. Evidence for behaviour change or an increase in sexually transmitted infections was not found. Conclusions: PrEP is safe and effective in MSM, serodiscordant couples and PWIDs. Additional research is needed prior to recommending PrEP in heterosexuals. No RCTs reported effectiveness or safety data for other high-risk groups, such as transgender women and sex workers. PROSPERO registration number: CRD42017065937.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gotzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · BMJ · doi:10.1136/bmj.b2700 · Cited by 17,648
Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.
Grant, R. M., Lama, J. R., Anderson, P. L., McMahan, V., Liu, A. Y., Vargas, L., Goicochea, P., Casapía, M., Guanira-Carranza, J. V., Ramirez-Cardich, M. E., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1011205 · Cited by 5,096
Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.
Baeten, J. M., Donnell, D., Ndase, P., Mugo, N. R., Campbell, J. D., Wangisi, J., Tappero, J. W., Bukusi, E. A., Cohen, C. R., Katabira, E., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1108524 · Cited by 3,256
Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana.
Thigpen, M. C., Kebaabetswe, P. M., Paxton, L. A., Smith, D. K., Rose, C. E., Segolodi, T. M., Henderson, F. L., Pathak, S. R., Soud, F. A., Chillag, K. L., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1110711 · Cited by 1,996
McCormack, S., Dunn, D. T., Desai, M., Dolling, D. I., Gafos, M., Gilson, R., Sullivan, A. K., Clarke, A., Reeves, I., Schembri, G., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00056-2 · Cited by 1,878
On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection
Molina, J.-M., Capitant, C., Spire, B., Pialoux, G., Cotte, L., Charreau, I., Tremblay, C., Le Gall, J.-M., Cua, E., Pasquet, A., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1506273 · Cited by 1,633
Preexposure Prophylaxis for HIV Infection among African Women
Van Damme, L., Corneli, A., Ahmed, K., Agot, K., Lombaard, J., Kapiga, S., Malahleha, M., Owino, F., Manongi, R., Onyango, J., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1202614 · Cited by 1,603
Choopanya, K., Martin, M., Suntharasamai, P., Sangkum, U., Mock, P. A., Leethochawalit, M., Chiamwongpaet, S., Kitisin, P., Natrujirote, P., Kittimunkong, S., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)61127-7 · Cited by 1,463
Tenofovir-based preexposure prophylaxis for HIV infection among African women.
Marrazzo, J. M., Ramjee, G., Richardson, B. A., Gomez, K., Mgodi, N., Nair, G., Palanee, T., Nakabiito, C., van der Straten, A., Noguchi, L., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1402269 · Cited by 1,296
Grant, R. M., Anderson, P. L., McMahan, V., Liu, A., Amico, K. R., Mehrotra, M., Hosek, S., Mosquera, C., Casapia, M., Montoya, O., et al. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)70847-3 · Cited by 1,208
Molina, J.-M., Charreau, I., Spire, B., Cotte, L., Chas, J., Capitant, C., Tremblay, C., Rojas-Castro, D., Cua, E., Pasquet, A., et al. (2017) · The Lancet HIV · doi:10.1016/s2352-3018(17)30089-9 · Cited by 472
Arcsine test for publication bias in meta‐analyses with binary outcomes
Rücker, G., Schwarzer, G., & Carpenter, J. (2008) · Statistics in Medicine · doi:10.1002/sim.2971 · Cited by 444
Mayer, K. H., Molina, J.-M., Thompson, M. A., Anderson, P. L., Mounzer, K. C., De Wet, J. J., DeJesus, E., Jessen, H., Grant, R. M., Ruane, P. J., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31065-5 · Cited by 428
Peterson, L., Taylor, D., Roddy, R., Belai, G., Phillips, P., Nanda, K., Grant, R., Clarke, E. E. K., Doh, A. S., Ridzon, R., et al. (2007) · PLoS Clinical Trials · doi:10.1371/journal.pctr.0020027 · Cited by 277
Hosek, S. G., Siberry, G., Bell, M., Lally, M., Kapogiannis, B., Green, K., Isabel Fernandez, M., Rutledge, B., Martinez, J., Garofalo, R., et al. (2013) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3182801081 · Cited by 173
Grohskopf, L. A., Chillag, K. L., Gvetadze, R., Liu, A. Y., Thompson, M., Mayer, K. H., Collins, B. M., Pathak, S. R., O'Hara, B., Ackers, M. L., et al. (2013) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31828ece33 · Cited by 172
Cheng, J., Pullenayegum, E., Marshall, J. K., Iorio, A., & Thabane, L. (2016) · BMJ Open · doi:10.1136/bmjopen-2015-010983 · Cited by 162
Mutua, G. N., Sanders, E. J., Mugo, P. M., Anzala, O. A., Haberer, J. E., Bangsberg, D. R., Barin, B., Rooney, J. F., Mark, D., Chetty, P., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033103 · Cited by 158
Antiretroviral pre-exposure prophylaxis (PrEP) for preventing HIV in high-risk individuals
Okwundu, C. I., & Okoromah, C. A. N. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007189.pub2 · Cited by 133
Baeten, J. M., Donnell, D. J., Mugo, N., Ndase, P., Thomas, K. K., Campbell, J. D., Wangisi, J., Tappero, J. W., Bukusi, E. A., Cohen, C. R., et al. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)70937-5 · Cited by 130
Bekker, L., Roux, S., Sebastien, E., Yola, N., Amico, K. R., Hughes, J. P., Marzinke, M. A., Hendrix, C. W., Anderson, P. L., Elharrar, V., et al. (2017) · The Lancet HIV · doi:10.1016/s2352-3018(17)30156-x · Cited by 125
Antiretroviral pre-exposure prophylaxis (PrEP) for preventing HIV in high-risk individuals
Okwundu, C. I., Uthman, O. A., & Okoromah, C. A. N. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007189.pub3 · Cited by 115
Ogbuagu, O. E., Ruane, P. J., Podzamczer, D., Salazar, L. C., Henry, K., Asmuth, D. M., Wohl, D. A., Gilson, R. J. C., Shao, Y., Ebrahimi, R., et al. (2021) · The Lancet HIV · doi:10.1016/s2352-3018(21)00071-0 · Cited by 105
Kibengo, F., Ruzagira, E., Katende, D., Naggirinya, A. B., Bahemuka, U. M., Haberer, J. E., Bangsberg, D. R., Barin, B., Rooney, J. F., Mark, D., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074314 · Cited by 86
Freeborn, K., & Portillo, C. J. (2017) · Journal of Clinical Nursing · doi:10.1111/jocn.13990 · Cited by 79
Huang, X., Hou, J., Song, A., Liu, X., Yang, X., Xu, J., Zhang, J., Hu, Q., Chen, H., Chen, Y., et al. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00799 · Cited by 70
Beisemann, M., Doebler, P., & Holling, H. (2020) · Biometrical Journal · doi:10.1002/bimj.201900379 · Cited by 27
Meta‐analysis of studies with bivariate binary outcomes: a marginal beta‐binomial model approach
Chen, Y., Hong, C., Ning, Y., & Su, X. G. (2015) · Statistics in Medicine · doi:10.1002/sim.6620 · Cited by 22
Metadata
- Authors
- O Murchu, E., Marshall, L., Teljeur, C., Harrington, P., Hayes, C., Moran, P., & Ryan, M.
- Venue
- BMJ Open
- Publisher
- BMJ
- Published
- 2022-05
- Volume
- 12
- Issue
- 5
- Pages
- e048478
- ISSN
- 2044-6055 (ISSN-L)
- OpenAlex
- W4280565035
- Cited by
- 263
- References
- 28
- FWCI
- 10.36
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.